Livzon Pharmaceutical Group Inc
SZSE:000513

Watchlist Manager
Livzon Pharmaceutical Group Inc Logo
Livzon Pharmaceutical Group Inc
SZSE:000513
Watchlist
Price: 36.82 CNY -3.18% Market Closed
Market Cap: 34B CNY
Have any thoughts about
Livzon Pharmaceutical Group Inc?
Write Note

Livzon Pharmaceutical Group Inc
Other Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Livzon Pharmaceutical Group Inc
Other Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Equity CAGR 3Y CAGR 5Y CAGR 10Y
Livzon Pharmaceutical Group Inc
SZSE:000513
Other Equity
-ÂĄ5.5m
CAGR 3-Years
60%
CAGR 5-Years
29%
CAGR 10-Years
13%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Other Equity
ÂĄ136.9m
CAGR 3-Years
N/A
CAGR 5-Years
14%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Other Equity
ÂĄ2.3m
CAGR 3-Years
-78%
CAGR 5-Years
-59%
CAGR 10-Years
N/A
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Other Equity
ÂĄ18.5m
CAGR 3-Years
N/A
CAGR 5-Years
44%
CAGR 10-Years
N/A
Yunnan Baiyao Group Co Ltd
SZSE:000538
Other Equity
-ÂĄ36.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Other Equity
ÂĄ1.4m
CAGR 3-Years
-23%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Livzon Pharmaceutical Group Inc
Glance View

Market Cap
34B CNY
Industry
Pharmaceuticals

Livzon Pharmaceutical Group Inc is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Zhuhai, Guangdong and currently employs 8,580 full-time employees. LIVZON PHARMACEUTICAL GROUP INC. is a China based company principally engaged in the research and development, production and sales of pharmaceutical products. The firm's main products include western medicine preparation such as gastrointestinal drugs, cardiovascular drugs and antimicrobial drugs and gonadotrophin drugs, Chinese medicine preparation, active pharmaceutical ingredient and intermediates, diagnostic reagents and equipments. The firm distributes its products in the domestic market and to overseas markets.

Intrinsic Value
48.61 CNY
Undervaluation 24%
Intrinsic Value
Price

See Also

What is Livzon Pharmaceutical Group Inc's Other Equity?
Other Equity
-5.5m CNY

Based on the financial report for Jun 30, 2024, Livzon Pharmaceutical Group Inc's Other Equity amounts to -5.5m CNY.

What is Livzon Pharmaceutical Group Inc's Other Equity growth rate?
Other Equity CAGR 10Y
13%

The average annual Other Equity growth rates for Livzon Pharmaceutical Group Inc have been 60% over the past three years , 29% over the past five years , and 13% over the past ten years .

Back to Top